Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1 1

Status

Recruiting 14Completed 12Withdrawn 3Unknown 3Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Oncogenic osteomalacia 2Neuroendocrine Tumors 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × gallium Ga 68 dotatate × Clear all
NCT04689893 2021-01-05

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Peking Union Medical College Hospital

Phase 1 Unknown
50 enrolled

Oncogenic osteomalacia

NCT04041882 2019-08-01

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01524016 2017-04-07

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled

Oncogenic osteomalacia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡